rs398124167
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001164508.2(NEB):c.1152+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000418 in 1,436,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001164508.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.1152+1G>T | splice_donor_variant, intron_variant | Intron 13 of 181 | ENST00000427231.7 | NP_001157979.2 | ||
NEB | NM_001164508.2 | c.1152+1G>T | splice_donor_variant, intron_variant | Intron 13 of 181 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.1152+1G>T | splice_donor_variant, intron_variant | Intron 13 of 181 | 5 | NM_001164508.2 | ENSP00000380505.3 | |||
NEB | ENST00000427231.7 | c.1152+1G>T | splice_donor_variant, intron_variant | Intron 13 of 181 | 5 | NM_001164507.2 | ENSP00000416578.2 | |||
NEB | ENST00000489048.1 | n.51+1G>T | splice_donor_variant, intron_variant | Intron 1 of 11 | 1 | |||||
NEB | ENST00000409198.5 | c.1152+1G>T | splice_donor_variant, intron_variant | Intron 13 of 149 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000912 AC: 2AN: 219184Hom.: 0 AF XY: 0.0000170 AC XY: 2AN XY: 117492
GnomAD4 exome AF: 0.00000418 AC: 6AN: 1436136Hom.: 0 Cov.: 29 AF XY: 0.00000421 AC XY: 3AN XY: 712106
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:2
This sequence change affects a donor splice site in intron 13 of the NEB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individual(s) with nemaline myopathy (PMID: 21798101). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 974957). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Nemaline myopathy Pathogenic:1
Variant summary: NEB c.1152+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5 splicing donor site. The variant allele was found at a frequency of 9.1e-06 in 219184 control chromosomes (gnomAD). c.1152+1G>T has been reported in the literature, in compound heterozygous state, in two siblings with severe Nemaline Myopathy, arthrogryposis and neonatal death (e.g. Lawlor_2011). These data indicate that the variant is likely to be associated with disease. Muscle biopsies from the affected siblings exhibited significantly lower levels of detectable nebulin protein than those in normal control muscle biopsies. Mechanical studies of skinned myofibers revealed marked impairment of force development, with an increase in tension cost. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Other variants affecting the same nucleotide (e.g. c.1152+1G>C, c.1152+1G>A) have been classified as pathogenic via internal testing and in ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. -
Arthrogryposis multiplex congenita 6 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at